July 15, 2025

High treatment success among individuals with rifampicin-resistant tuberculosis in Botswana: A retrospective cohort study

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Retrospective cohort study reports 84.6% treatment success in individuals with rifampicin-resistant TB, highlighting challenges among PLWH.

Treatment success among individuals with rifampicin-resistant tuberculosis reached 84.6%, indicating effective intervention strategies.
The study analyzed data from 162 individuals between 2016 and 2023, focusing on treatment outcomes and predictors.
Results showed higher mortality among people living with HIV at 10.7%, compared to 6.6% for those not living with HIV.
Findings emphasize the need for targeted interventions for high-risk groups, particularly among patients with a history of TB treatment.

Mogashoa et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective cohort study reports 84.6% treatment success in individuals with rifampicin-resistant TB, highlighting challenges among PLWH.